Clinical Trial Update: Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of sorafenib, pemetrexed, and cisplatin in patients with advanced solid tumors; the study is completed and includes mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Mesothelioma
• Pancreatic Cancer
• Prostate Cancer
• Sarcoma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• Nexavar (Sorafenib)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED